Wordt geladen...
How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making?
Antibiotics have revolutionized the treatment of bacterial infections. However, it is widely held that there is underinvestment in antibiotics research and development relative to the socially optimal level for a number of reasons. In this article, we discuss whether existing health technology asses...
Bewaard in:
| Gepubliceerd in: | MDM Policy Pract |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935770/ https://ncbi.nlm.nih.gov/pubmed/31910245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468319892237 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|